Ashleigh Palmer, Provention Bio CEO
With FDA decision one month away, Provention partners with Sanofi on US marketing for type 1 diabetes drug
Though its FDA decision is one month away, Provention Bio has already begun its commercial efforts for its type 1 diabetes drug — and it’s now …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.